MedPath

PAMIDRONATE DISODIUM FOR INJECTION

PAMIDRONATE DISODIUM FOR INJECTION

Approved
DIN Number

02244552

Drug Class

Human

Market Date

Aug 31, 2001

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02244552
AIG Number0123608006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M05BA03 PAMIDRONIC ACID
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification92:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PAMIDRONATE DISODIUMActive
Strength: 9 MG / ML
Monograph: PAMIDRONATE DISODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.